Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
Regulatory FDF Prices
NA
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. 3-(1-biphenyl-4-ylmethyl-3-ethoxycarbonyl-1-butylcarbamoyl)propionate-3'-methyl-2'-(pentanoyl(2'-(tetrazol-5-ylate)biphenyl-4'-ylmethyl)amino)butyrate
2. Lcz 696
3. Lcz-696
4. Lcz696
5. Sacubitril And Valsartan Drug Combination
6. Sacubitril And Valsartan Sodium Anhydrous Drug Combination
7. Sacubitril And Valsartan Sodium Hydrate Drug Combination
8. Sacubitril Valsartan Drug Combination
9. Sacubitril Valsartan Sodium Anhydrous
10. Sacubitril Valsartan Sodium Hydrate
11. Sacubitril-valsartan
12. Sacubitril-valsartan Sodium Anhydrous Drug Combination
13. Sacubitril-valsartan Sodium Hydrate Drug Combination
14. Trisodium (3-(1-biphenyl-4-ylmethyl-3-ethoxycarbonyl-1-butylcarbamoyl)propionate-3'-methyl-2'-(pentanoyl(2'-(tetrazol-5-ylate)biphenyl-4'-ylmethyl)amino)butyrate) Hemipentahydrate
1. Sacubitril Valsartan Sodium Hydrate
2. Sacubitril Mixture With Valsartan
3. Wb8ft61183
4. Lcz 696
5. Sacubitril Valsartan Sodium Hydrate (jan)
6. Sacubitril Valsartan Sodium Hydrate [jan]
7. Entresto (tn)
8. Unii-wb8ft61183
9. Valsartan Mixture With Ahu-377
10. Ex-a2849
11. Mfcd29477717
12. 3-(1-biphenyl-4-ylmethyl-3-ethoxycarbonyl-1-butylcarbamoyl)propionate-3'-methyl-2'-(pentanoyl(2'-(tetrazol-5-ylate)biphenyl-4'-ylmethyl)amino)butyrate
13. Ac-29037
14. Sucabitril Valsartan Sodium Hydrate
15. Trisodium (3-(1-biphenyl-4-ylmethyl-3-ethoxycarbonyl-1-butylcarbamoyl)propionate-3'-methyl-2'-(pentanoyl(2'-(tetrazol-5-ylate)biphenyl-4'-ylmethyl)amino)butyrate) Hemipentahydrate
16. D10226
17. Valsartan Ahu-377 Sodium Hemipentahydrate
18. Q27292546
19. L-valine, N-(1-oxopentyl)-n-((2'-(2h-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, Compd. With .alpha.-ethyl (.alpha.r,.gamma.s)-.gamma.-((3-carboxy-1-oxopropyl)amino)-.alpha.-methyl(1,1'-biphenyl)-4-pentanoate, Sodium Salt, Hydrate (2:2:6:5)
20. L-valine, N-(1-oxopentyl)-n-((2'-(2h-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, Compd. With Alpha-ethyl(alphar,gammas)-gamma-((3-carboxy-1-oxopropyl)amino)-alpha-methyl(1,1'-biphenyl)-4-pentanoate, Sodium Salt, Hydrate (2:2:6:5)
| Molecular Weight | 1916.0 g/mol |
|---|---|
| Molecular Formula | C96H120N12Na6O21 |
| Hydrogen Bond Donor Count | 7 |
| Hydrogen Bond Acceptor Count | 29 |
| Rotatable Bond Count | 40 |
| Exact Mass | 1915.8110694 g/mol |
| Monoisotopic Mass | 1914.8077146 g/mol |
| Topological Polar Surface Area | 396 Ų |
| Heavy Atom Count | 135 |
| Formal Charge | 0 |
| Complexity | 1140 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 6 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 15 |
Entresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.
Angiotensin Receptor Antagonists
Agents that antagonize ANGIOTENSIN RECEPTORS. Many drugs in this class specifically target the ANGIOTENSIN TYPE 1 RECEPTOR. (See all compounds classified as Angiotensin Receptor Antagonists.)
C09DX04
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Reviewed
Rev. Date : 2017-12-22
Pay. Date : 2017-11-08
DMF Number : 31574
Submission : 2017-08-29
Status : Active
Type : II
Date of Issue : 2022-07-28
Valid Till : 2025-11-30
Written Confirmation Number : WC-0390
Address of the Firm :
Registrant Name : Sangjin Trading Co., Ltd.
Registration Date : 2022-04-25
Registration Number : Su583-30-ND
Manufacturer Name : Dr. Reddy's Laboratories Limited@M/s Chromo Laboratories India Pvt Ltd.@Dr. Reddy's Laboratories Limited
Manufacturer Address : CTO-SEZ Process Unit-01, Sector No.'s 28 to 34, 36 to 37, 40, 50 to 53, Survey No.'s 57 to 58, 60, 72 to 73, 76 to 77 & 80, Devunipalavalasa Village, Ranasthalam Mandal, Srikakulam District 532409, Andhra Pradesh, India@Plot 43 & 44, IDA, Phase-II, PASHAMYLARAM, PATANCHERU, SANGAREDDY, PASHAMYLARAM(V), PATANCHERU(M), SANGAREDDY(DIST.), 502307, India@CTO-VI, APIIC Industrial Estate, Pydibhimavaram, Ranasthalam Mandal, Srikakulam District, Andhra Pradesh – 532 409 India
Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.
Delivering quality and niche Active Pharmaceutical Ingredients across the global from our USFDA-approved facility.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36637
Submission : 2022-01-17
Status : Active
Type : II
Registrant Name : Lihu Healthcare Co., Ltd.
Registration Date : 2023-01-27
Registration Number : Su382-8-ND
Manufacturer Name : Mankind Pharma Limited@Shree Jee Laboratory Private Limited
Manufacturer Address : 208, Okhla Industrial Estate, Phase-3, New Delhi-110020, India@C-24 &25, RIICO Industrial Area, Sotanala, Behror - 301701, Dist. Alwar (Rajasthan), India
| Available Reg Filing : ASMF |
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37994
Submission : 2023-03-09
Status : Active
Type : II
Date of Issue : 2025-08-05
Valid Till : 2028-06-25
Written Confirmation Number : WC-0054
Address of the Firm :
European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.
GDUFA
DMF Review : Reviewed
Rev. Date : 2018-09-04
Pay. Date : 2017-12-20
DMF Number : 32337
Submission : 2017-12-21
Status : Active
Type : II
| Available Reg Filing : ASMF |
Octavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
Shanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Complete
Rev. Date : 2017-12-22
Pay. Date : 2017-11-08
DMF Number : 31574
Submission : 2017-08-29
Status : Active
Type : II
Delivering quality and niche Active Pharmaceutical Ingredients across the global from our USFDA-approved facility.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36637
Submission : 2022-01-17
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37994
Submission : 2023-03-09
Status : Active
Type : II
European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.
GDUFA
DMF Review : Complete
Rev. Date : 2018-09-04
Pay. Date : 2017-12-20
DMF Number : 32337
Submission : 2017-12-21
Status : Active
Type : II
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
GDUFA
DMF Review : Complete
Rev. Date : 2019-04-12
Pay. Date : 2018-12-20
DMF Number : 33457
Submission : 2019-02-28
Status : Active
Type : II
Honour is a leading global CDMO and specialty chemicals manufacturer with seven world-class sites delivering quality-driven solutions.
GDUFA
DMF Review : Complete
Rev. Date : 2019-06-20
Pay. Date : 2019-05-07
DMF Number : 33657
Submission : 2019-05-09
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 33344
Submission : 2019-03-15
Status : Inactive
Type : II

GDUFA
DMF Review : Complete
Rev. Date : 2019-04-30
Pay. Date : 2019-04-15
DMF Number : 33398
Submission : 2018-12-31
Status : Active
Type : II

GDUFA
DMF Review : Complete
Rev. Date : 2019-02-19
Pay. Date : 2018-10-31
DMF Number : 32325
Submission : 2017-12-30
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 32171
Submission : 2017-12-16
Status : Active
Type : II

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Date of Issue : 2022-07-28
Valid Till : 2025-11-30
Written Confirmation Number : WC-0390
Address of the Firm : Devunipalavalasa Village, Ranasthalam Mandal, Srikakulam District -532409, Andhr...
Sacubitril Valsartan Trisodium Salt Hemipentahydrate IH
Date of Issue : 2025-08-05
Valid Till : 2028-06-25
Written Confirmation Number : WC-0054
Address of the Firm : Block No. 82/B, ECP Road, At & Post Karakhadi, Tal - Padra, Dist. Baroda, Gujara...
Honour is a leading global CDMO and specialty chemicals manufacturer with seven world-class sites delivering quality-driven solutions.
Sacubitril Valsartan Sodium Hydrate IH
Date of Issue : 2025-09-03
Valid Till : 2028-09-02
Written Confirmation Number : WC-0362
Address of the Firm : Plot No:4, Hetero Infrastructure SEZ Ltd.,Narasapuram, Visakhapatnam-531081, And...
Honour is a leading global CDMO and specialty chemicals manufacturer with seven world-class sites delivering quality-driven solutions.
Sacubutril Valsartan Sodium on Colloidal SiliconDioxide IH
Date of Issue : 2025-09-03
Valid Till : 2028-09-02
Written Confirmation Number : WC-0362
Address of the Firm : Plot No:4, Hetero Infrastructure SEZ Ltd.,Narasapuram, Visakhapatnam-531081, And...
Sacubitril Valsartan Trisodium Hemipentahydrate IH
Date of Issue : 2025-08-22
Valid Till : 2028-08-21
Written Confirmation Number : WC-0082
Address of the Firm : Karakhadi, Plot No. 842-843, At - Karakhdi, Tal. - Padra, Dist -Vadodara, Gujara...

Date of Issue : 2024-07-18
Valid Till : 2027-06-07
Written Confirmation Number : WC-0317
Address of the Firm : Plot No. 43 & 44, IDA Phase-ll, Pashamylaram, Pashamylaram(V), Patancheru (M), S...

Sacubitril Valsartan Sodium Hydrate IH IH
Date of Issue : 2025-06-27
Valid Till : 2028-06-16
Written Confirmation Number : WC-0030
Address of the Firm : M/s. Divi \'s Laboratories Limited, Unit-2 Annavaram (Post), Chippada Village,Bh...

Date of Issue : 2025-10-16
Valid Till : 2028-07-21
Written Confirmation Number : WC-0044
Address of the Firm : Plot No. A-100, A-100/1, A-100/2 & D-1, M.I.D.C Ind. Area, Shendra, Aurangabad-4...

Date of Issue : 2023-09-25
Valid Till : 2026-03-20
Written Confirmation Number : WC-0453
Address of the Firm : Plot NO.E-41,129&128/2, MIDCInd.Area,Tarapur,Boisar-401 506, Maharashtra, India

Sacubitril Valsartan 3Na Complex IH
Date of Issue : 2025-09-24
Valid Till : 2028-09-23
Written Confirmation Number : WC-0213
Address of the Firm : Unit-I, Plot No.21, Jawaharlal Nehru Pharma City, Parawada Mandal, Anakapalli Di...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Approved
Registration Country : Sweden
Sacubitril Sodium|Valsartan Disodium
Brand Name : Sacubitril/Valsartan Accord
Dosage Form : Film Coated Tablet
Dosage Strength : 24mg;26mg
Packaging :
Approval Date : 14/07/2025
Application Number : 20231127000046
Regulatory Info : Approved
Registration Country : Sweden

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Approved
Registration Country : Sweden
Sacubitril Sodium|Valsartan Disodium
Brand Name : Sacubitril/Valsartan Accord
Dosage Form : Film Coated Tablet
Dosage Strength : 49mg;51mg
Packaging :
Approval Date : 14/07/2025
Application Number : 20231127000053
Regulatory Info : Approved
Registration Country : Sweden

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Approved
Registration Country : Sweden
Sacubitril Sodium|Valsartan Disodium
Brand Name : Sakubitril/Valsartan Devatis
Dosage Form : Film Coated Tablet
Dosage Strength : 49mg;51mg
Packaging :
Approval Date : 14/07/2025
Application Number : 20231127000022
Regulatory Info : Approved
Registration Country : Sweden

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Entresto
Dosage Form : Film Coated Tablet
Dosage Strength : 97.2mg;102.8mg
Packaging :
Approval Date : 17/09/2015
Application Number : 65673
Regulatory Info : Allowed
Registration Country : Switzerland

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Entresto mg
Dosage Form : Granules
Dosage Strength : 6mg;6mg
Packaging :
Approval Date : 21/08/2024
Application Number : 69255
Regulatory Info : Allowed
Registration Country : Switzerland

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Approved
Registration Country : Sweden
Sakubitril-Valsartannatriumhydrat
Brand Name : Entresto
Dosage Form : Film Coated Tablet
Dosage Strength : 24mg;26mg
Packaging :
Approval Date : 19/11/2015
Application Number : 20141220000037
Regulatory Info : Approved
Registration Country : Sweden

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Approved
Registration Country : Sweden
Sakubitril-Valsartannatriumhydrat
Brand Name : Entresto
Dosage Form : Capsule
Dosage Strength :
Packaging :
Approval Date : 26/05/2023
Application Number : 20220620000011
Regulatory Info : Approved
Registration Country : Sweden

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Approved
Registration Country : Sweden
Sakubitril-Valsartannatriumhydrat
Brand Name : Entresto
Dosage Form : Film Coated Tablet
Dosage Strength : 97mg;103mg
Packaging :
Approval Date : 19/11/2015
Application Number : 20141220000051
Regulatory Info : Approved
Registration Country : Sweden

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Approved
Registration Country : Sweden
Sakubitril-Valsartannatriumhydrat
Brand Name : Neparvis
Dosage Form : Film Coated Tablet
Dosage Strength : 24mg;26mg
Packaging :
Approval Date : 26/05/2016
Application Number : 20160119000033
Regulatory Info : Approved
Registration Country : Sweden

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Approved
Registration Country : Sweden
Sakubitril-Valsartannatriumhydrat
Brand Name : Neparvis
Dosage Form : Film Coated Tablet
Dosage Strength : 49mg;51mg
Packaging :
Approval Date : 26/05/2016
Application Number : 20160119000040
Regulatory Info : Approved
Registration Country : Sweden

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Global Sales Information
Market Place
Reply
16 Sep 2025
Reply
23 Aug 2025
Reply
16 Sep 2024
Reply
24 Jun 2023
Reply
22 May 2023
Reply
01 Oct 2022
Reply
09 Sep 2022
Reply
05 Sep 2022
Reply
26 Jul 2022
Reply
30 Jun 2022
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
80
PharmaCompass offers a list of Sacubitril-Valsartan API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Sacubitril-Valsartan manufacturer or Sacubitril-Valsartan supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sacubitril-Valsartan manufacturer or Sacubitril-Valsartan supplier.
PharmaCompass also assists you with knowing the Sacubitril-Valsartan API Price utilized in the formulation of products. Sacubitril-Valsartan API Price is not always fixed or binding as the Sacubitril-Valsartan Price is obtained through a variety of data sources. The Sacubitril-Valsartan Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Sacubitril-Valsartan manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sacubitril-Valsartan, including repackagers and relabelers. The FDA regulates Sacubitril-Valsartan manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sacubitril-Valsartan API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Sacubitril-Valsartan manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Sacubitril-Valsartan supplier is an individual or a company that provides Sacubitril-Valsartan active pharmaceutical ingredient (API) or Sacubitril-Valsartan finished formulations upon request. The Sacubitril-Valsartan suppliers may include Sacubitril-Valsartan API manufacturers, exporters, distributors and traders.
click here to find a list of Sacubitril-Valsartan suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Sacubitril-Valsartan DMF (Drug Master File) is a document detailing the whole manufacturing process of Sacubitril-Valsartan active pharmaceutical ingredient (API) in detail. Different forms of Sacubitril-Valsartan DMFs exist exist since differing nations have different regulations, such as Sacubitril-Valsartan USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Sacubitril-Valsartan DMF submitted to regulatory agencies in the US is known as a USDMF. Sacubitril-Valsartan USDMF includes data on Sacubitril-Valsartan's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Sacubitril-Valsartan USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Sacubitril-Valsartan suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Sacubitril-Valsartan Drug Master File in Korea (Sacubitril-Valsartan KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Sacubitril-Valsartan. The MFDS reviews the Sacubitril-Valsartan KDMF as part of the drug registration process and uses the information provided in the Sacubitril-Valsartan KDMF to evaluate the safety and efficacy of the drug.
After submitting a Sacubitril-Valsartan KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Sacubitril-Valsartan API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Sacubitril-Valsartan suppliers with KDMF on PharmaCompass.
A Sacubitril-Valsartan written confirmation (Sacubitril-Valsartan WC) is an official document issued by a regulatory agency to a Sacubitril-Valsartan manufacturer, verifying that the manufacturing facility of a Sacubitril-Valsartan active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Sacubitril-Valsartan APIs or Sacubitril-Valsartan finished pharmaceutical products to another nation, regulatory agencies frequently require a Sacubitril-Valsartan WC (written confirmation) as part of the regulatory process.
click here to find a list of Sacubitril-Valsartan suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Sacubitril-Valsartan as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Sacubitril-Valsartan API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Sacubitril-Valsartan as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Sacubitril-Valsartan and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Sacubitril-Valsartan NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Sacubitril-Valsartan suppliers with NDC on PharmaCompass.
Sacubitril-Valsartan Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sacubitril-Valsartan GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sacubitril-Valsartan GMP manufacturer or Sacubitril-Valsartan GMP API supplier for your needs.
A Sacubitril-Valsartan CoA (Certificate of Analysis) is a formal document that attests to Sacubitril-Valsartan's compliance with Sacubitril-Valsartan specifications and serves as a tool for batch-level quality control.
Sacubitril-Valsartan CoA mostly includes findings from lab analyses of a specific batch. For each Sacubitril-Valsartan CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sacubitril-Valsartan may be tested according to a variety of international standards, such as European Pharmacopoeia (Sacubitril-Valsartan EP), Sacubitril-Valsartan JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sacubitril-Valsartan USP).